Neoadjuvant Chemotherapy Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Some breast cancer patients on neoadjuvant chemo may avoid axillary lymph node dissection
(American Association for Cancer Research) Axillary lymph node dissection could be avoided by certain early-stage breast cancer patients receiving neoadjuvant chemotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 7, 2016 Category: Cancer & Oncology Source Type: news

Primary Surgery Tops Neoadjuvant Chemo in Epithelial Ovarian Cancer?
A retrospective review showed that primary cytoreductive surgery was associated with longer survival than neoadjuvant chemotherapy in women with advanced-stage epithelial ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - November 30, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gynecologic Cancers News Ovarian Cancer Source Type: news

Primary Cytoreductive Surgery: Improved Survival in Ovarian Cancer Primary Cytoreductive Surgery: Improved Survival in Ovarian Cancer
Otherwise healthy women with advanced-stage epithelial ovarian cancer who undergo primary cytoreductive surgery (PCS) have improved survival compared with those who receive neoadjuvant chemotherapy (NACT), according to Boston-based researchers.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 29, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Presurgical endocrine therapy less toxic than chemotherapy for ER-positive breast cancer
(Massachusetts General Hospital) Neoadjuvant endocrine therapy -- designed to reduce the size of breast tumors before surgical removal -- appears to be as effective as neoadjuvant chemotherapy for patients with localized, estrogen-receptor (ER)-positive breast cancer with considerably fewer side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 9, 2016 Category: Cancer & Oncology Source Type: news

Surgery timing after neoadjuvant chemoradiation in Stage IIIA NSCLC impacts OS
(International Association for the Study of Lung Cancer) The timing of surgery after neoadjuvant chemoradiation in patients with stage IIIA non-small cell lung cancer affects the overall survival of patients receiving trimodality therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 5, 2016 Category: Cancer & Oncology Source Type: news

Longer Gap Between Chemo, Esophageal Resection Tied to Better Response Longer Gap Between Chemo, Esophageal Resection Tied to Better Response
In patients with esophageal cancer, increasing the interval between neoadjuvant chemoradiotherapy and resection beyond six weeks is associated with better odds of pathologic complete response, according to a new study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 26, 2016 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Neoadjuvant Tx Tops Surgery for Pancreatic Ca (CME/CE)
(MedPage Today) -- Chemo improved survival versus surgery and adjuvant therapy in newly diagnosed patients (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - September 16, 2016 Category: Gastroenterology Source Type: news

Neoadjuvant Chemo Favored in Advanced Ovarian Cancer Neoadjuvant Chemo Favored in Advanced Ovarian Cancer
The use of neoadjuvant chemotherapy is increasing for the treatment of advanced ovarian cancer, and is being favored over surgery.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 9, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Better Survival With Surgery in Stage IIIC Ovarian Cancer
Over a 10-year period, the use of neoadjuvant chemotherapy increased significantly in women with advanced ovarian cancer, according to a new observational study. (Source: CancerNetwork)
Source: CancerNetwork - September 7, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gynecologic Cancers News Ovarian Cancer Source Type: news

ASCO & SGO: Neoadjuvant Chemo Now a Standard for Ovarian Cancer ASCO & SGO: Neoadjuvant Chemo Now a Standard for Ovarian Cancer
Two major oncology professional societies have now come out in support of a role for neoadjuvant chemotherapy for ovarian cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 30, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

ASCO, SGO Clarify Chemo Role in Ovarian Cancer (CME/CE)
(MedPage Today) -- High clinical risk, low surgical success favor neoadjuvant therapy (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 10, 2016 Category: Hematology Source Type: news

Neoadjuvant Chemo for Ovarian Ca Highlighted in New Guidelines Neoadjuvant Chemo for Ovarian Ca Highlighted in New Guidelines
Joint guidelines on the preferred treatment for advanced ovarian and related cancers aim to improve the quality of care for women with stage IIIC and IV invasive disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

ASCO Issues Guideline on Neoadjuvant Chemotherapy for Advanced Ovarian Cancer
In a new practice guideline, the American Society of Clinical Oncology offered recommendations on the use of neoadjuvant chemotherapy and interval cytoreduction for women with stage IIIC or IV epithelial ovarian cancer. (Source: CancerNetwork)
Source: CancerNetwork - August 8, 2016 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gynecologic Cancers News Ovarian Cancer Source Type: news

French Researchers Find Shorter Mesothelioma Survival with Neoadjuvant...
A new study suggests that peritoneal mesothelioma patients may want to think twice about delaying surgery to have chemotherapy first.(PRWeb August 01, 2016)Read the full story at http://www.prweb.com/releases/2016/08/prweb13587396.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 1, 2016 Category: Pharmaceuticals Source Type: news

Eliminating Breast Cancer Surgery in Exceptional RespondersEliminating Breast Cancer Surgery in Exceptional Responders
Is surgery redundant in breast cancer patients who had a complete response to neoadjuvant chemotherapy? Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 8, 2016 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news